Anterior uveitis is intraocular inflammation of the iris and ciliary body. While topical treatment is often the first step, a subset of patients fail to achieve adequate control with local therapy alone, or present with a recurrent, bilateral course — both scenarios that call for a different management strategy.
This protocol targets anterior uveitis that is not adequately controlled by topical drugs alone, or that is recurrent and bilateral. In these presentations, escalation beyond local therapy is required.
Management in this setting involves systemic oral corticosteroid therapy.
DOI: 10.4103/0301-4738.58468
Systemic corticosteroids are indicated when the anterior uveitis is not responding to topical drugs alone or if the disease is recurrent and bilateral.
Start with high dose and taper according to the clinical response.
View source ↗